$CBIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CATALYST BIOSCIENCES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CATALYST BIOSCIENCES, INC.. Get notifications about new insider transactions in CATALYST BIOSCIENCES, INC. for free.
Page: < prev 1 2 3 4 5 6 7 ... 8 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 01 2012 | CBIO | CATALYST BIOSCIENC ... | BURRILL STEVEN | Director | Buy | M | 0.08 | 4,333 | 325 | 4,333 | 0 to 4.3 K |
Jun 13 2012 | CBIO | CATALYST BIOSCIENC ... | SKALETSKY MARK B | Member, Office of t ... | Option Exercise | A | 4.20 | 57,500 | 241,500 | 57,500 | |
Jun 11 2012 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Buy | P | 4.16 | 7,500 | 31,193 | 7,500 | 0 to 7.5 K |
Jun 11 2012 | CBIO | CATALYST BIOSCIENC ... | BARRETT M JAMES | Director | Option Exercise | A | 4.16 | 7,500 | 31,200 | 7,500 | |
Jun 08 2012 | CBIO | CATALYST BIOSCIENC ... | SNYDERMAN RALPH | Director | Option Exercise | A | 4.16 | 7,500 | 31,200 | 7,500 | |
Jun 08 2012 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Option Exercise | A | 4.16 | 7,500 | 31,200 | 7,500 | |
Jun 08 2012 | CBIO | CATALYST BIOSCIENC ... | DUNTON ALAN W | Director | Option Exercise | A | 4.16 | 7,500 | 31,200 | 7,500 | |
Jun 08 2012 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Option Exercise | A | 4.16 | 7,500 | 31,200 | 7,500 | |
Jun 08 2012 | CBIO | CATALYST BIOSCIENC ... | BURRILL STEVEN | Director | Option Exercise | A | 4.16 | 7,500 | 31,200 | 7,500 | |
Jun 08 2012 | CBIO | CATALYST BIOSCIENC ... | BROWN JULIA R | Director | Option Exercise | A | 4.16 | 7,500 | 31,200 | 7,500 | |
Jun 08 2012 | CBIO | CATALYST BIOSCIENC ... | BLIXT CHARLES A | Director | Option Exercise | A | 4.16 | 7,500 | 31,200 | 7,500 | |
May 22 2012 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | SVP, Preclinical Re ... | Option Exercise | M | 2.93 | 15,938 | 46,698 | 7,970 | |
May 22 2012 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | SVP, Preclinical Re ... | Buy | M | 2.93 | 15,938 | 46,698 | 15,938 | 0 to 15.9 K |
May 08 2012 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | SVP, Lgl Affrs, GC ... | Option Exercise | A | 4.59 | 100,000 | 459,000 | 100,000 | |
May 08 2012 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Option Exercise | A | 4.59 | 135,000 | 619,650 | 135,000 | |
May 08 2012 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | SVP - Bus. & Commer ... | Option Exercise | A | 4.59 | 100,000 | 459,000 | 100,000 | |
May 08 2012 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Option Exercise | A | 4.59 | 100,000 | 459,000 | 100,000 | |
May 08 2012 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Option Exercise | A | 4.59 | 60,000 | 275,400 | 60,000 | |
May 08 2012 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | SVP, Preclinical Re ... | Option Exercise | A | 4.59 | 90,000 | 413,100 | 90,000 | |
May 08 2012 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin+Corp Sys and ... | Option Exercise | A | 4.59 | 60,000 | 275,400 | 60,000 | |
Feb 16 2012 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Option Exercise | M | 5.10 | 798 | 4,070 | 0 | |
Feb 16 2012 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Buy | M | 5.10 | 798 | 4,070 | 798 | 0 to 798 |
Sep 29 2011 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Gift | G | 0.00 | 500 | 0 | 500 | 0 to 500 |
Sep 29 2011 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Gift | G | 0.00 | 500 | 0 | 6,735 | 7.2 K to 6.7 K (-6.91 %) |
Sep 29 2011 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Gift | G | 0.00 | 500 | 0 | 7,235 | 7.7 K to 7.2 K (-6.46 %) |
Jul 06 2011 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Option Exercise | M | 9.27 | 2,500 | 23,175 | 2,500 | |
Jul 06 2011 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Sell | S | 21.02 | 2,500 | 52,550 | 5,333 | 7.8 K to 5.3 K (-31.92 %) |
Jul 06 2011 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Buy | M | 9.27 | 2,500 | 23,175 | 7,833 | 5.3 K to 7.8 K (+46.88 %) |
Jun 17 2011 | CBIO | CATALYST BIOSCIENC ... | BARRETT M JAMES | Director | Option Exercise | A | 21.25 | 7,500 | 159,375 | 7,500 | |
Jun 17 2011 | CBIO | CATALYST BIOSCIENC ... | SNYDERMAN RALPH | Director | Option Exercise | A | 21.25 | 7,500 | 159,375 | 7,500 | |
Jun 17 2011 | CBIO | CATALYST BIOSCIENC ... | SKALETSKY MARK B | Director | Option Exercise | A | 21.25 | 12,500 | 265,625 | 12,500 | |
Jun 17 2011 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Option Exercise | A | 21.25 | 7,500 | 159,375 | 7,500 | |
Jun 17 2011 | CBIO | CATALYST BIOSCIENC ... | DUNTON ALAN W | Director | Option Exercise | A | 21.25 | 7,500 | 159,375 | 7,500 | |
Jun 17 2011 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Option Exercise | A | 21.25 | 7,500 | 159,375 | 7,500 | |
Jun 17 2011 | CBIO | CATALYST BIOSCIENC ... | BROWN JULIA R | Director | Option Exercise | A | 21.25 | 7,500 | 159,375 | 7,500 | |
Jun 17 2011 | CBIO | CATALYST BIOSCIENC ... | BURRILL STEVEN | Director | Option Exercise | A | 21.25 | 7,500 | 159,375 | 7,500 | |
Jun 17 2011 | CBIO | CATALYST BIOSCIENC ... | BLIXT CHARLES A | Director | Option Exercise | A | 21.25 | 7,500 | 159,375 | 7,500 | |
Jun 08 2011 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Option Exercise | M | 5.55 | 16,368 | 90,842 | 49,107 | |
Jun 08 2011 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Option Exercise | M | 5.63 | 2,880 | 16,200 | 0 | |
Jun 08 2011 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Option Exercise | M | 5.10 | 11,627 | 59,298 | 0 | |
Jun 08 2011 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Sell | S | 21.80 | 30,875 | 672,973 | 2,799 | 33.7 K to 2.8 K (-91.69 %) |
Jun 08 2011 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Buy | M | 5.55 | 16,368 | 90,842 | 33,674 | 17.3 K to 33.7 K (+94.58 %) |
Jun 08 2011 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Buy | M | 5.63 | 2,880 | 16,200 | 17,306 | 14.4 K to 17.3 K (+19.96 %) |
Jun 08 2011 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Buy | M | 5.10 | 11,627 | 59,298 | 14,426 | 2.8 K to 14.4 K (+415.40 %) |
May 13 2011 | CBIO | CATALYST BIOSCIENC ... | BROWN JULIA R | Director | Option Exercise | M | 8.70 | 9,100 | 79,170 | 3,400 | |
May 13 2011 | CBIO | CATALYST BIOSCIENC ... | BROWN JULIA R | Director | Sell | S | 23.38 | 9,100 | 212,782 | 0 | 9.1 K to 0 (-100.00 %) |
May 13 2011 | CBIO | CATALYST BIOSCIENC ... | BROWN JULIA R | Director | Buy | M | 8.70 | 9,100 | 79,170 | 9,100 | 0 to 9.1 K |
May 12 2011 | CBIO | CATALYST BIOSCIENC ... | BURRILL STEVEN | Director | Option Exercise | M | 2.71 | 7,500 | 20,325 | 0 | |
May 12 2011 | CBIO | CATALYST BIOSCIENC ... | BURRILL STEVEN | Director | Option Exercise | M | 7.10 | 7,500 | 53,250 | 0 | |
May 12 2011 | CBIO | CATALYST BIOSCIENC ... | BURRILL STEVEN | Director | Option Exercise | M | 9.27 | 7,500 | 69,525 | 0 | |
May 12 2011 | CBIO | CATALYST BIOSCIENC ... | BURRILL STEVEN | Director | Option Exercise | M | 9.37 | 7,500 | 70,275 | 0 | |
May 12 2011 | CBIO | CATALYST BIOSCIENC ... | BURRILL STEVEN | Director | Option Exercise | M | 9.37 | 3,052 | 28,597 | 0 | |
May 12 2011 | CBIO | CATALYST BIOSCIENC ... | BURRILL STEVEN | Director | Option Exercise | M | 9.37 | 16,948 | 158,803 | 3,052 | |
May 12 2011 | CBIO | CATALYST BIOSCIENC ... | BURRILL STEVEN | Director | Sell | S | 23.88 | 33,052 | 789,345 | 0 | 33.1 K to 0 (-100.00 %) |
May 12 2011 | CBIO | CATALYST BIOSCIENC ... | BURRILL STEVEN | Director | Buy | M | 2.71 | 7,500 | 20,325 | 33,052 | 25.6 K to 33.1 K (+29.35 %) |
May 12 2011 | CBIO | CATALYST BIOSCIENC ... | BURRILL STEVEN | Director | Buy | M | 7.10 | 7,500 | 53,250 | 25,552 | 18.1 K to 25.6 K (+41.55 %) |
May 12 2011 | CBIO | CATALYST BIOSCIENC ... | BURRILL STEVEN | Director | Buy | M | 9.27 | 7,500 | 69,525 | 18,052 | 10.6 K to 18.1 K (+71.08 %) |
May 12 2011 | CBIO | CATALYST BIOSCIENC ... | BURRILL STEVEN | Director | Buy | M | 9.37 | 10,552 | 98,872 | 10,552 | 0 to 10.6 K |
May 12 2011 | CBIO | CATALYST BIOSCIENC ... | BURRILL STEVEN | Director | Sell | S | 24.13 | 2,000 | 48,253 | 0 | 2 K to 0 (-100.00 %) |
May 12 2011 | CBIO | CATALYST BIOSCIENC ... | BURRILL STEVEN | Director | Sell | S | 24.04 | 16,948 | 407,471 | 0 | 16.9 K to 0 (-100.00 %) |
May 12 2011 | CBIO | CATALYST BIOSCIENC ... | BURRILL STEVEN | Director | Buy | M | 9.37 | 16,948 | 158,803 | 16,948 | 0 to 16.9 K |
Apr 04 2011 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Option Exercise | M | 9.27 | 2,500 | 23,175 | 5,000 | |
Apr 04 2011 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Sell | S | 26.60 | 2,500 | 66,500 | 5,333 | 7.8 K to 5.3 K (-31.92 %) |
Apr 04 2011 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Buy | M | 9.27 | 2,500 | 23,175 | 7,833 | 5.3 K to 7.8 K (+46.88 %) |
Apr 04 2011 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Option Exercise | M | 2.93 | 2,655 | 7,779 | 18,595 | |
Apr 04 2011 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Sell | S | 26.37 | 2,655 | 70,012 | 7,735 | 10.4 K to 7.7 K (-25.55 %) |
Apr 04 2011 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Buy | M | 2.93 | 2,655 | 7,779 | 10,390 | 7.7 K to 10.4 K (+34.32 %) |
Mar 31 2011 | CBIO | CATALYST BIOSCIENC ... | Zorn Peter A | SVP, Lgl Affrs, GC ... | Option Exercise | A | 26.05 | 50,000 | 1,302,500 | 50,000 | |
Mar 31 2011 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Option Exercise | A | 26.05 | 50,000 | 1,302,500 | 50,000 | |
Mar 31 2011 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin+Corp Sys and ... | Option Exercise | A | 26.05 | 30,500 | 794,525 | 30,500 | |
Mar 31 2011 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Option Exercise | A | 26.05 | 30,500 | 794,525 | 30,500 | |
Mar 31 2011 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | A | 26.05 | 55,500 | 1,445,775 | 55,500 | |
Mar 31 2011 | CBIO | CATALYST BIOSCIENC ... | deBethizy J Donald | President and CEO | Option Exercise | A | 26.05 | 105,000 | 2,735,250 | 105,000 | |
Mar 31 2011 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Option Exercise | A | 26.05 | 40,000 | 1,042,000 | 40,000 | |
Mar 31 2011 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | SVP - Bus. & Commer ... | Option Exercise | A | 26.05 | 50,000 | 1,302,500 | 50,000 | |
Mar 31 2011 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | SVP, Preclinical Re ... | Option Exercise | A | 26.05 | 40,000 | 1,042,000 | 40,000 | |
Mar 11 2011 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Option Exercise | M | 5.55 | 1,500 | 8,325 | 6,198 | |
Mar 11 2011 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Sell | S | 30.00 | 1,500 | 45,000 | 1,159 | 2.7 K to 1.2 K (-56.41 %) |
Mar 11 2011 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Buy | M | 5.55 | 1,500 | 8,325 | 2,659 | 1.2 K to 2.7 K (+129.42 %) |
Mar 09 2011 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Option Exercise | M | 5.55 | 500 | 2,775 | 7,698 | |
Mar 09 2011 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Option Exercise | M | 5.55 | 5,030 | 27,917 | 8,198 | |
Mar 09 2011 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Sell | S | 30.00 | 500 | 15,001 | 1,159 | 1.7 K to 1.2 K (-30.14 %) |
Mar 09 2011 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Buy | M | 5.55 | 500 | 2,775 | 1,659 | 1.2 K to 1.7 K (+43.14 %) |
Mar 09 2011 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Sell | S | 30.00 | 5,030 | 150,900 | 1,159 | 6.2 K to 1.2 K (-81.27 %) |
Mar 09 2011 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Buy | M | 5.55 | 5,030 | 27,917 | 6,189 | 1.2 K to 6.2 K (+433.99 %) |
Mar 03 2011 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Option Exercise | M | 5.55 | 200 | 1,110 | 13,228 | |
Mar 03 2011 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Option Exercise | M | 5.55 | 12,703 | 70,502 | 13,428 | |
Mar 03 2011 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Sell | S | 30.00 | 200 | 6,000 | 1,159 | 1.4 K to 1.2 K (-14.72 %) |
Mar 03 2011 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Buy | M | 5.55 | 200 | 1,110 | 1,359 | 1.2 K to 1.4 K (+17.26 %) |
Mar 03 2011 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Sell | S | 30.16 | 12,703 | 383,144 | 1,159 | 13.9 K to 1.2 K (-91.64 %) |
Mar 03 2011 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Buy | M | 5.55 | 12,703 | 70,502 | 13,862 | 1.2 K to 13.9 K (+1,096.03 %) |
Mar 03 2011 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | SVP - Bus. & Commer ... | Option Exercise | M | 2.93 | 1,264 | 3,704 | 31,394 | |
Mar 03 2011 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | SVP - Bus. & Commer ... | Sell | S | 30.00 | 1,264 | 37,920 | 0 | 1.3 K to 0 (-100.00 %) |
Mar 03 2011 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | SVP - Bus. & Commer ... | Buy | M | 2.93 | 1,264 | 3,704 | 1,264 | 0 to 1.3 K |
Mar 02 2011 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Option Exercise | M | 8.51 | 11,360 | 96,674 | 31,472 | |
Mar 02 2011 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Option Exercise | M | 5.55 | 15,481 | 85,920 | 0 | |
Mar 02 2011 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Sell | S | 30.00 | 11,360 | 340,800 | 7,735 | 19.1 K to 7.7 K (-59.49 %) |
Mar 02 2011 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Buy | M | 8.51 | 11,360 | 96,674 | 19,095 | 7.7 K to 19.1 K (+146.86 %) |
Mar 02 2011 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Sell | S | 28.00 | 15,481 | 433,468 | 7,735 | 23.2 K to 7.7 K (-66.68 %) |
Mar 02 2011 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Buy | M | 5.55 | 15,481 | 85,920 | 23,216 | 7.7 K to 23.2 K (+200.14 %) |
Mar 03 2011 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Option Exercise | M | 8.51 | 775 | 6,595 | 2,325 | |
Mar 03 2011 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Option Exercise | M | 8.32 | 468 | 3,894 | 32 | |
Mar 03 2011 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Sell | S | 30.00 | 1,243 | 37,290 | 0 | 1.2 K to 0 (-100.00 %) |
Mar 03 2011 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Buy | M | 8.51 | 775 | 6,595 | 1,243 | 468 to 1.2 K (+165.60 %) |
Mar 03 2011 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Buy | M | 8.32 | 468 | 3,894 | 468 | 0 to 468 |
Feb 18 2011 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Option Exercise | M | 2.93 | 16,655 | 48,799 | 21,250 | |
Feb 18 2011 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Sell | S | 26.52 | 16,655 | 441,656 | 7,735 | 24.4 K to 7.7 K (-68.29 %) |
Feb 18 2011 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Buy | M | 1.75 | 16,655 | 29,146 | 24,390 | 7.7 K to 24.4 K (+215.32 %) |
Jan 20 2011 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Option Exercise | M | 2.71 | 5,000 | 13,550 | 0 | |
Jan 20 2011 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Option Exercise | M | 2.71 | 2,500 | 6,775 | 5,000 | |
Jan 20 2011 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Sell | S | 27.11 | 5,000 | 135,543 | 5,333 | 10.3 K to 5.3 K (-48.39 %) |
Jan 20 2011 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Buy | M | 2.71 | 5,000 | 13,550 | 10,333 | 5.3 K to 10.3 K (+93.76 %) |
Jan 20 2011 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Sell | S | 27.38 | 2,500 | 68,440 | 5,333 | 7.8 K to 5.3 K (-31.92 %) |
Jan 20 2011 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Buy | M | 2.71 | 2,500 | 6,775 | 7,833 | 5.3 K to 7.8 K (+46.88 %) |
Jan 20 2011 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | SVP, Preclinical Re ... | Option Exercise | M | 1.75 | 22,252 | 38,941 | 0 | |
Jan 20 2011 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | SVP, Preclinical Re ... | Option Exercise | M | 5.55 | 7,951 | 44,128 | 0 | |
Jan 20 2011 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | SVP, Preclinical Re ... | Option Exercise | M | 5.55 | 22,800 | 126,540 | 7,951 | |
Jan 20 2011 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | SVP, Preclinical Re ... | Sell | S | 27.09 | 30,203 | 818,257 | 0 | 30.2 K to 0 (-100.00 %) |
Jan 20 2011 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | SVP, Preclinical Re ... | Buy | M | 1.75 | 22,252 | 38,941 | 30,203 | 8 K to 30.2 K (+279.86 %) |
Jan 20 2011 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | SVP, Preclinical Re ... | Buy | M | 5.55 | 7,951 | 44,128 | 7,951 | 0 to 8 K |
Jan 20 2011 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | SVP, Preclinical Re ... | Sell | S | 27.17 | 22,800 | 619,476 | 0 | 22.8 K to 0 (-100.00 %) |
Jan 20 2011 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | SVP, Preclinical Re ... | Buy | M | 5.55 | 22,800 | 126,540 | 22,800 | 0 to 22.8 K |
Jan 13 2011 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Option Exercise | M | 2.93 | 5,225 | 15,309 | 18,838 | |
Jan 13 2011 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Option Exercise | M | 8.51 | 6,006 | 51,111 | 3,100 | |
Jan 13 2011 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Option Exercise | M | 8.51 | 3,294 | 28,032 | 9,106 | |
Jan 13 2011 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Option Exercise | M | 5.55 | 10,531 | 58,447 | 0 | |
Jan 13 2011 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Sell | S | 27.18 | 11,231 | 305,298 | 0 | 11.2 K to 0 (-100.00 %) |
Jan 13 2011 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Buy | M | 2.93 | 5,225 | 15,309 | 11,231 | 6 K to 11.2 K (+87.00 %) |
Jan 13 2011 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Buy | M | 8.51 | 6,006 | 51,111 | 6,006 | 0 to 6 K |
Jan 13 2011 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Sell | S | 27.02 | 13,825 | 373,571 | 0 | 13.8 K to 0 (-100.00 %) |
Jan 13 2011 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Buy | M | 8.51 | 3,294 | 28,032 | 13,825 | 10.5 K to 13.8 K (+31.28 %) |
Jan 13 2011 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Buy | M | 5.55 | 10,531 | 58,447 | 10,531 | 0 to 10.5 K |
Jan 18 2011 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Option Exercise | M | 2.93 | 1,719 | 5,037 | 13,750 | |
Jan 18 2011 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Option Exercise | M | 2.93 | 3,369 | 9,871 | 15,469 | |
Jan 18 2011 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Sell | S | 27.50 | 1,719 | 47,273 | 0 | 1.7 K to 0 (-100.00 %) |
Jan 18 2011 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Buy | M | 2.93 | 1,719 | 5,037 | 1,719 | 0 to 1.7 K |
Jan 18 2011 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Sell | S | 27.24 | 3,369 | 91,760 | 0 | 3.4 K to 0 (-100.00 %) |
Jan 18 2011 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Buy | M | 2.93 | 3,369 | 9,871 | 3,369 | 0 to 3.4 K |
Dec 23 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Option Exercise | M | 5.10 | 4,881 | 24,893 | 11,627 | |
Dec 23 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Option Exercise | M | 5.10 | 6,746 | 34,405 | 16,508 | |
Dec 23 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Option Exercise | M | 5.10 | 8,789 | 44,824 | 0 | |
Dec 23 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Sell | S | 26.47 | 4,881 | 129,200 | 2,799 | 7.7 K to 2.8 K (-63.55 %) |
Dec 23 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Buy | M | 5.10 | 4,881 | 24,893 | 7,680 | 2.8 K to 7.7 K (+174.38 %) |
Dec 23 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Sell | S | 26.61 | 15,535 | 413,386 | 2,799 | 18.3 K to 2.8 K (-84.73 %) |
Dec 23 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Buy | M | 5.10 | 15,535 | 79,229 | 18,334 | 2.8 K to 18.3 K (+555.02 %) |
Dec 21 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 6,782 | 11,869 | 0 | |
Dec 21 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 2,100 | 3,675 | 0 | |
Dec 21 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 2,100 | 3,675 | 2,100 | |
Dec 21 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Sell | S | 26.02 | 8,882 | 231,120 | 1,153 | 10 K to 1.2 K (-88.51 %) |
Dec 21 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Buy | M | 1.75 | 8,882 | 15,544 | 10,035 | 1.2 K to 10 K (+770.34 %) |